Company Filing History:
Years Active: 2018
Title: Jihoon Jang: Innovator in Histone Methyltransferase Inhibition
Introduction
Jihoon Jang is a prominent inventor based in Ansan-si, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target histone methyltransferases. His innovative work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Jihoon Jang holds a patent for "Quinoline derivatives for inhibiting histone methyltransferases and use thereof." This patent describes a quinoline derivative that inhibits the activity of histone methyltransferases, specifically ESET/SETDB1, which is crucial for the histone molecule H3K9. The invention also includes pharmaceutically acceptable salts of the compound, highlighting its potential for medical applications.
Career Highlights
Jihoon Jang is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in the field of biochemistry. His work focuses on the synthesis and application of novel compounds that can modulate biological processes at the epigenetic level.
Collaborations
Jihoon collaborates with esteemed colleagues, including Hyunah Choo and Sun-Joon Min, to advance research in his field. Their combined expertise fosters a productive environment for innovation and discovery.
Conclusion
Jihoon Jang's contributions to the field of histone methyltransferase inhibition exemplify the importance of innovative research in biochemistry. His patent and ongoing work at the Korea Institute of Science and Technology position him as a key figure in the development of new therapeutic strategies.